Tilray: Numbers Keep Getting Worse
- Tilray reported another quarter of highly disappointing results, yet the stock again rallied initially on the numbers.
- The Canadian cannabis company missed analyst revenue targets by ~10%.
- The stock remains far too expensive at over 12x key cannabis and beverage revenues.
- Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio. Learn More »